5MX-65272-32073
1 vaccination
7 coded responses
15 check-ins
7 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 064 / CT
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-21
Dose 1 — Pfizer-BioNTech
-
2021-03-22
Registered in v-safe
-
2021-03-22
Survey response — days 1–6 daily, dose 1MedDRA: Emergency care, Hypersensitivity, Pre-existing disease — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Recovering fom Allergic reaction from vaccine actively managing asthma · Healthcare visit (other): Emergency care after shot, follow up management today, tomorrowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-23
Survey response — days 1–6 daily, dose 1MedDRA: Hypersensitivity, Wheezing — Feeling: Poor · Fatigue or tiredness · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Continued wheezing after allergic reaction to vaccine · Healthcare visit (other): Requesting plan to resolve wheezing such as continue prednisoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction, Wheezing — Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Continued wheezing from adverse reactionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-25
Survey response — days 1–6 daily, dose 1MedDRA: Immunisation reaction, Pre-existing disease — Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Asthma symptoms decreasing after adverse reactionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction, Asthma — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Adverse reaction (asthma) slowly improving with additional medicationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-27
Survey response — days 1–6 daily, dose 1MedDRA: Asthma, Wheezing — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Asthma/wheezing symptoms improvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Survey response — day 7, dose 1MedDRA: Adverse reaction — Feeling: Fair · Fatigue or tirednessFree text: Breathing improving 7 days post severe adverse reactionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-04-11
- 2021-04-18
- 2021-04-26
- 2021-05-02
- 2021-06-20
- 2021-09-19
-
2022-01-03
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2022-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-21 | Pfizer-BioNTech |
Call center
4 call center cases
4 successful
VAERS report filed, before or during a call: 4
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Recovering fom Allergic reaction from vaccine actively managing asthma
Healthcare visit (other): Emergency care after shot, follow up management today, tomorrow
Systemic reaction (other): Continued wheezing after allergic reaction to vaccine
Healthcare visit (other): Requesting plan to resolve wheezing such as continue prednisone
Systemic reaction (other): Continued wheezing from adverse reaction
Systemic reaction (other): Asthma symptoms decreasing after adverse reaction
Systemic reaction (other): Adverse reaction (asthma) slowly improving with additional medication
Systemic reaction (other): Asthma/wheezing symptoms improving
Release 6 — day 7, dose 1
Systemic reaction (other): Breathing improving 7 days post severe adverse reaction
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | ✓ | ✓ | ✓ |
| HCVO | Wheezing | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Asthma | ✓ | ✓ | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Immunisation reaction | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Wheezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release